Phytobioactive compound-based nanodelivery systems for the treatment of type 2 diabetes mellitus – current status
Palanivel Ganesan,1,2 Palanisamy Arulselvan,3 Dong-Kug Choi1,2 1Nanotechnology Research Center and Department of Applied Life Science, 2Department of Biotechnology, College of Biomedical and Health Science, Konkuk University, Chungju, Republic of Korea; 3Laboratory of Vaccines and Immunotherapeutics...
Guardado en:
Autores principales: | Ganesan P, Arulselvan P, Choi DK |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f10b0a476c0e4ee3b4e935afc2961deb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Microfluidization trends in the development of nanodelivery systems and applications in chronic disease treatments
por: Ganesan P, et al.
Publicado: (2018) -
Bioactive Compounds and Nanodelivery Perspectives for Treatment of Cardiovascular Diseases
por: Rakesh K. Sindhu, et al.
Publicado: (2021) -
Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases
por: Ganesan P, et al.
Publicado: (2018) -
Current application of phytocompound-based nanocosmeceuticals for beauty and skin therapy
por: Ganesan P, et al.
Publicado: (2016) -
Antibacterial and anticancer activity of seaweeds and bacteria associated with their surface
por: Villarreal-Gómez,Luis J, et al.
Publicado: (2010)